logo-loader
viewDelta Air Lines

Delta Air Lines, Fastenal Company, BlackRock , Fed minutes - PRE-MARKET

Proactive takes a look at the stocks ion play in pre-market deals in New York

1507723170_JetRefuelling.jpg
Delta Air Lines' third quarter numbers beat expectations

US futures are pointing to a lower start after yesterday's highs and ahead of the closely- watched minutes of the last Federal Reserve policy meeting are published.

Delta Air Lines Inc (NYSE:DAL) saw shares fly 1.9% higher at US$53.70 after hours. Before the bell on Wednesday, the group posted third quarter revenue and earnings that beat the 'Street's' expectations.

Earnings per share (EPS) for the three months was US$ $1.57 compared to the $1.53 a share, which had been expected.

Revenue at the second largest US carrier totalled US$11.06bn in the quarter against US$11.03bn expected.

The key passenger revenue per available seat mile  figure rose 1.9% - in line with the airline's updated forecast earlier last month.

Elsewhere, goods distributor Fastenal Company (NASDAQ:FAST) saw shares plunge  0.78% to US$44.51 in pre-market.

It is expected before the bell to report quarterly earnings at US$0.50 a share on revenues of US$1.12bn billion before the opening bell.

Analysts are expecting BlackRock Inc (NYSE:BLK), the investment management giant, to have earned US$5.49 per share on revenues of $3.08BN in its latest three months.

Shares in the firm added 0.32% to US$467 after hours.

Quick facts: Delta Air Lines

Price: 56.71 USD

NYSE:DAL
Market: NYSE
Market Cap: $36.68 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Polarean Imaging achieves positive phase III results in two...

Polarean Imaging PLC (LON:POLX) CEO Richard Hullihen tells Proactive its two phase III clinical trials have 'demonstrated handily' that its technology allows doctors and surgeons to visualize aspects of lung function that have gone undetected using traditional magnetic resonances imaging (MRI)...

52 minutes ago

2 min read